Inhibition of mucin release from airway goblet cells by polycationic peptides
OwnerKwang Chul Kiminventor
Life of this patent
Estimating the term…
Abstract
Polycationic peptides have been shown to be effective inhibitors of mucin secretion. Inhibition of mucin secretion using these polycationic peptides may be an important tool in the treatment of diseases associated with mucin hypersecretion, including asthma, chronic bronchitis, cystic fibrosis, and bronchiectasis.
Claims20
A method of reducing mucin production in the airways of an animal comprising administering at least one polycationic molecule to the airways of the animal.
A composition comprising at least one polycationic polypeptide and at least one inhalation adjuvant.
A device for administering a polycationic peptide to the airways of an animal comprising an inhalator containing a polycationic peptide.
Dependencies are inferred from the claim text.